uu.seUppsala University Publications
Change search
ReferencesLink to record
Permanent link

Direct link
Preparation of piperazinyl quinazolines as 5-HT6 modulators.
2007 (English)Patent (Other (popular science, discussion, etc.))Text
Abstract [en]

Title compds. represented by the formula I [wherein Q = (hetero)arylalkyl; R1 = OH, halo, alkyl, etc.; R2, R3 = independently H, (halo)alkyl, aminocarbonylalkyl, etc.; n = 0-3; and pharmaceutically acceptable salts, solvates or solvated salts thereof] were prepd. as 5-HT6 modulators. For example, reaction of 2-chloro-4-(4-methylpiperazin-1-yl)quinazoline with N-methyl-4-chlorobenzenesulfonamide gave II in 10% yield. The radioligand binding assay showed II having Ki of 200 nM. Thus, I and their pharmaceutical compns. are useful for the treatment of 5-HT6 mediated disorders, such as Alzheimer's disease, schizophrenia, obesity or Parkinson's disease. [on SciFinder(R)]

Place, publisher, year, edition, pages
AstraZeneca AB, Swed. . , 2007. no WO2007108744A2
Keyword [en]
quinazoline piperazinyl benzenesulfonamide prepn 5HT6 modulator, Alzheimer schizophrenia obesity Parkinson disease treatment piperazinylquinazolinyl benzenesulfonamide prepn
National Category
Medicinal Chemistry
URN: urn:nbn:se:uu:diva-270236OAI: oai:DiVA.org:uu-270236DiVA: diva2:888187

CAPLUS AN 2007:1091014(Patent)

Available from: 2015-12-22 Created: 2015-12-22 Last updated: 2015-12-22

Open Access in DiVA

No full text

Search in DiVA

By author/editor
Yngve, Ulrika.
Medicinal Chemistry

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Total: 51 hits
ReferencesLink to record
Permanent link

Direct link